Vimian Group AB (publ)
Vimian Group AB (publ) (VIMGF) Financial Performance & Income Statement Overview
Analyze Vimian Group AB (publ) (VIMGF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Vimian Group AB (publ) (VIMGF) Income Statement & Financial Overview
Analyze Vimian Group AB (publ)’s VIMGF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $107.50M | $104.90M | $87.65M | $90.99M |
| Cost of Revenue | $32.70M | $35.20M | $26.43M | $26.82M |
| Gross Profit | $74.80M | $69.70M | $61.22M | $64.17M |
| Gross Profit Ratio | $0.70 | $0.66 | $0.70 | $0.71 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $41.20M |
| Operating Expenses | $59.20M | $57.20M | $51.13M | $50.94M |
| Total Costs & Expenses | $91.90M | $92.40M | $77.56M | $77.77M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $9.00M | $8.70M | $8.33M | $8.40M |
| EBITDA | $24.60M | $21.30M | $18.42M | $22.72M |
| EBITDA Ratio | $0.23 | $0.20 | $0.21 | $0.25 |
| Operating Income | $15.60M | $12.50M | $10.09M | $13.22M |
| Operating Income Ratio | $0.15 | $0.12 | $0.12 | $0.15 |
| Other Income/Expenses (Net) | -$7.50M | $2.40M | -$9.35M | -$5.50M |
| Income Before Tax | $8.10M | $14.90M | $743000.00 | $7.72M |
| Income Before Tax Ratio | $0.08 | $0.14 | $0.008 | $0.08 |
| Income Tax Expense | $3.40M | $2.40M | $2.68M | $2.66M |
| Net Income | $4.30M | $12.20M | -$2.13M | $4.87M |
| Net Income Ratio | $0.04 | $0.12 | -$0.02 | $0.05 |
| EPS | $0.01 | $0.02 | -$0.004 | $0.11 |
| Diluted EPS | $0.01 | $0.02 | -$0.004 | $0.11 |
| Weighted Avg Shares Outstanding | $523.89M | $523.89M | $522.42M | $510.94M |
| Weighted Avg Shares Outstanding (Diluted) | $524.33M | $524.56M | $522.72M | $511.00M |
The company's financials show resilient growth, with revenue advancing from $90.99M in Q2 2024 to $107.50M in Q1 2025. Gross profit remained healthy with margins at 70% in Q1 2025 compared to 71% in Q2 2024. Operating income hit $15.60M last quarter, sustaining a consistent 15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $24.60M. Net income dropped to $4.30M, while earnings per share reached $0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan